IGF-dependent and IGF-independent actions of IGF-binding protein-1 and -2: implications for metabolic homeostasis.
about
IGF-Binding Protein 2 - Oncogene or Tumor Suppressor?Effects of cord serum insulin, IGF-II, IGFBP-2, IL-6 and cortisol concentrations on human birth weight and length: pilot studyInsulin-like growth factor binding proteins: a structural perspective.Data Mining of Determinants of Intrauterine Growth Retardation Revisited Using Novel Algorithms Generating Semantic Maps and Prototypical Discriminating Variable ProfilesA Meta-analysis of Individual Participant Data Reveals an Association between Circulating Levels of IGF-I and Prostate Cancer RiskThe Role of the Growth Hormone/Insulin-Like Growth Factor System in Visceral Adiposity.Hepatic gene expression profiling reveals key pathways involved in leptin-mediated weight loss in ob/ob mice.Copeptin, IGFBP-1, and cardiovascular prognosis in patients with type 2 diabetes and acute myocardial infarction: a report from the DIGAMI 2 trial.Defining the pathway to insulin-like growth factor system targeting in cancer.The metabolic syndrome and ECG detected left ventricular hypertrophy--influences from IGF-1 and IGF-binding protein-1Interleukin-33 induces protective effects in adipose tissue inflammation during obesity in mice.Insulin-like growth factor binding proteins increase intracellular calcium levels in two different cell lines.IGFBP-4 and -5 are expressed in first-trimester villi and differentially regulate the migration of HTR-8/SVneo cells.Congenital leptin deficiency: diagnosis and effects of leptin replacement therapy.Insulin-like growth factor binding protein-2 level is increased in blood of lung cancer patients and associated with poor survival.Breastfeeding and its prospective association with components of the GH-IGF-Axis, insulin resistance and body adiposity measures in young adulthood--insights from linear and quantile regression analysis.Effects of human insulin and insulin aspart preparations on levels of IGF-I, IGFBPs and IGF bioactivity in patients with type 1 diabetes.Prediagnostic plasma IGFBP-1, IGF-1 and risk of prostate cancer.High IGFBP2 expression correlates with tumor severity in pediatric rhabdomyosarcoma.Insulin-like growth factors and related proteins in plasma and cerebrospinal fluids of HIV-positive individuals.Aerobic exercise training increases circulating insulin-like growth factor binding protein-1 concentration, but does not attenuate the reduction in circulating insulin-like growth factor binding protein-1 after a high-fat mealGender-specific effects on food intake but no inhibition of age-related fat accretion in transgenic mice overexpressing human IGFBP-2 lacking the Cardin-Weintraub sequence motif.Perfluorooctanoic acid exposure for 28 days affects glucose homeostasis and induces insulin hypersensitivity in miceGlobal Igfbp1 deletion does not affect prostate cancer development in a c-Myc transgenic mouse modelThe Insulin-Like Growth Factor System in Obesity, Insulin Resistance and Type 2 Diabetes MellitusIncreasing circulating IGFBP1 levels improves insulin sensitivity, promotes nitric oxide production, lowers blood pressure, and protects against atherosclerosisInsulin-like growth factor-binding protein-2 is required for osteoclast differentiation.Serum insulin-like growth factor binding protein 6 (IGFBP6) is increased in patients with type 1 diabetes and its complications.Insulin-like growth factor axis and risk of type 2 diabetes in womenMicrovascular management of systemic insulin sensitivity.Prediagnosis biomarkers of insulin-like growth factor-1, insulin, and interleukin-6 dysregulation and multiple myeloma risk in the Multiple Myeloma Cohort Consortium.Dissociation of somatic growth, time of sexual maturity, and life expectancy by overexpression of an RGD-deficient IGFBP-2 variant in female transgenic mice.IGF-Binding Proteins in Type-1 Diabetes Are More Severely Altered in the Presence of ComplicationsMetformin stimulates IGFBP-2 gene expression through PPARalpha in diabetic states.Effects of oral sodium bicarbonate in patients with CKDMatrix metalloproteinase 11 protects from diabesity and promotes metabolic switch.Hepatic Fatty Acid Oxidation Restrains Systemic Catabolism during Starvation.The heparin-binding domains of IGFBP-2 mediate its inhibitory effect on preadipocyte differentiation and fat development in male mice.IGFBP2/FAK pathway is causally associated with dasatinib resistance in non-small cell lung cancer cells.Association of Circulating IGFBP1 Level with the Severity of Coronary Artery Lesions in Patients with Unstable Angina.
P2860
Q27003443-973B0287-ED41-4EE0-A28D-27F5A79E9E91Q28478640-1D17E935-2A54-4C4B-B4E6-2494350414ABQ30417447-4708314F-EB93-4E21-BFB3-CEF0482F4A49Q30979460-763E4DD4-E76D-42E2-A13B-596AFAAA2A2FQ31049602-EA0E2D34-8FE3-4960-95D6-A7BD99C5CB5DQ33602919-CBD970CF-91C9-433B-8C8B-7340C467C0A0Q33680916-CB5A0E85-7E6A-4D1F-A4B0-696E7FB3362BQ33932812-15E844C5-DD7D-41E4-BD56-DA1A2AAF30BBQ34107722-832A1480-53D0-4A7D-A6D8-E14993E625B3Q34610977-2571572F-59AD-4277-8567-6C20C9634D18Q34626217-B76D0E80-CAE8-433F-B4E8-2B457725FA1AQ34634999-CCF45307-6526-481C-B066-AA04A022A0D0Q34740473-FF6A0999-47AA-442D-AE7E-5AAD6F34C424Q34856807-2521ED9B-C7B0-475A-B252-565F79E43B6DQ34999407-6CBB2A75-7708-4867-8E3B-AF16E8DF81F2Q35043824-248EEE34-EAF3-4D07-8A6A-95CAF0033AB5Q35146163-D0F3C8E5-2B0D-462F-AA44-0885F7483C81Q35178839-DE1062BA-522B-4E53-B639-2B98A5AD1A81Q35474529-E00CF979-3D12-4940-BFC0-D8B0DAE871B6Q35530481-AA249EC2-C473-471E-A53D-406ACCA29110Q35583259-923DB4AE-0C35-425C-B4FC-5DE097FC69B0Q35690618-C52C129C-44F1-4A2D-ABF3-BFD18CA11E9CQ35727717-3158079F-27EA-4E5E-8ABC-361F47AF0113Q35735568-0D979E65-05B5-4A95-8C2D-108605B398D3Q35750576-F22C63E2-E298-4626-89F0-A18DD20396CBQ35857746-F7951555-DE51-4C10-8AF9-F0A72332300EQ36064698-004014BF-3071-454C-84D2-2DC91AE3DDEAQ36111636-90D231AF-1052-4AAD-AB5E-8D8D0F7E7059Q36182551-5BA01463-A68F-4256-BCDE-550799578862Q36371123-099FB8B7-D4B6-4B0F-8234-D9B66DFB5657Q36474567-AFA7A73B-F95A-48F1-839B-7D73CE18D1EBQ36475243-B2C69A7A-A3BB-4EC9-987F-224CEE430826Q36516159-19ED6D65-DE15-4134-9E4D-9793FA299416Q36724703-717FDC8C-6072-40FF-8F51-27B4240AC02EQ36810485-6B4FC07F-D366-410D-B0A6-8D0AB9AF106EQ36850318-ABA8C887-E3BD-4160-808C-D9F9B6538A52Q37052937-E9385633-520A-4C3A-801D-E262D3B74D03Q37240147-6D779672-EB4D-405F-B954-F36939B91BA4Q37381182-E98A14CC-FCDC-459C-964B-8CFFB2DF3D69Q37681925-6FA10EBD-2FF1-4722-B8C2-10ED325D3EA2
P2860
IGF-dependent and IGF-independent actions of IGF-binding protein-1 and -2: implications for metabolic homeostasis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 06 April 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
IGF-dependent and IGF-independ ...... ons for metabolic homeostasis.
@en
IGF-dependent and IGF-independ ...... ons for metabolic homeostasis.
@en-gb
IGF-dependent and IGF-independ ...... ons for metabolic homeostasis.
@nl
type
label
IGF-dependent and IGF-independ ...... ons for metabolic homeostasis.
@en
IGF-dependent and IGF-independ ...... ons for metabolic homeostasis.
@en-gb
IGF-dependent and IGF-independ ...... ons for metabolic homeostasis.
@nl
prefLabel
IGF-dependent and IGF-independ ...... ons for metabolic homeostasis.
@en
IGF-dependent and IGF-independ ...... ons for metabolic homeostasis.
@en-gb
IGF-dependent and IGF-independ ...... ons for metabolic homeostasis.
@nl
P1476
IGF-dependent and IGF-independ ...... ons for metabolic homeostasis.
@en
P304
P356
10.1016/J.TEM.2009.01.002
P577
2009-04-06T00:00:00Z